Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 2/20 | 0.41 |
| ▸ | HRH1 | P35367 | 3/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.38 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.38 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.37 |
| ▸ | HTR2A | P28223 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SCN4A | P35499 | 5/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4356262 | 0.83 | RIPK1 (0.42) | RIPK1HRH1SLC6A3CACNA1FCHRM2 | |
| SCHEMBL9493203 | 0.79 | LMNA (0.43) | RIPK1HRH1SLC6A3CACNA1FCHRM2 | |
| SCHEMBL8608404 | 0.77 | RIPK1 (0.41) | RIPK1HRH1SLC6A3CACNA1FCHRM2 | |
| SCHEMBL8634300 | 0.77 | RIPK1 (0.44) | RIPK1HRH1SLC6A3CACNA1FCHRM2 | |
| SCHEMBL1823949 | 0.76 | TRPA1 (0.55) | RIPK1HRH1SLC6A3CACNA1FCHRM2 | |
| SCHEMBL8860874 | 0.76 | RIPK1 (0.44) | RIPK1HRH1SLC6A3CACNA1FCHRM2 | |
| SCHEMBL8607432 | 0.74 | RIPK1 (0.42) | RIPK1HRH1SLC6A3CACNA1FCHRM2 | |
| SCHEMBL708842 | 0.73 | RIPK1 (0.40) | RIPK1HRH1SLC6A3CACNA1FCHRM2 | |
| SCHEMBL327102 | 0.73 | RIPK1 (0.40) | RIPK1HRH1SLC6A3CACNA1FCHRM2 | |
| SCHEMBL704187 | 0.72 | RIPK1 (0.37) | RIPK1HRH1SLC6A3CACNA1FCHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090036659-A1 | METHOD OF DEUTERATING BENZYL-POSITION IN -O-BENZYL GROUP | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036659-A1 | METHOD OF DEUTERATING BENZYL-POSITION IN -O-BENZYL GROUP | DBH, BRD4, BRD3 | RIPK1 3139/4885HRH1 934/4885SLC6A3 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.